PROTANBIO is currently represented by Je-Yoel Cho, a professor of Seoul National University, College of Veterinary Medicine and a Chairman of the Korea Proteomics Society. PROTANBIO is a venture company of Seoul National University aming to establish protein markers utilizing proteomics. With our expertise, we are discovering new diagnostic markers for various diseases, ranging from lung cancer and breast cancer to mental illness using blood samples. Research experience over 15 years has led us to the most number of patents regarding domestic lung cancer biomarkers. In addition, PROTANBIO has developed lung cancer diagnostic kit that can detect early stages of lung cancer in an efficient and cost-effective method via blood. Simultaneously, we are developing Kit for an early diagnosis of mental illness and brain injuries. Recently, with our antibody technology, we have been expanding our research into the development of anti-cancer drugs such as CAR-T. We aim to become a globally established bio-company that values technology and innovation to prepare for the future. Thank you.